Atlas Trials

Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG

Clinical trial NCT07438860 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07438860
Sponsor
Tiffany Hodges
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Brain TumorsGlioma
Start date
2026-03-02
Primary completion
2026-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.